PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression

Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer patients following such first-line treatments. Therefore, targeted therapy according to the molecular cancer biology can be very important in reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghehchian, Negin, Maharati, Amirhosein, Akhlaghipour, Iman, Zangouei, Amir Sadra, Moghbeli, Meysam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561470/
https://www.ncbi.nlm.nih.gov/pubmed/37807067
http://dx.doi.org/10.1186/s12935-023-03086-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561470/
https://www.ncbi.nlm.nih.gov/pubmed/37807067
http://dx.doi.org/10.1186/s12935-023-03086-3

Ejemplares similares